TY - JOUR
T1 - Both amino- and carboxyl-terminal domains of TRAF3 negatively regulate NF-κB activation induced by OX40 signaling
AU - Takaori-Kondo, Akifumi
AU - Hori, Toshiyuki
AU - Fukunaga, Keiko
AU - Morita, Rinpei
AU - Kawamata, Shin
AU - Uchiyama, Takashi
N1 - Funding Information:
We are very grateful to Dr. W. C. Greene for providing expression vectors for NIK, IKKα, and their dominant negative mutants. This study was partly supported by grants-in-aid from the Ministry of Education, Science, and Culture of Japan.
PY - 2000/6/16
Y1 - 2000/6/16
N2 - OX40 is a member of the tumor necrosis factor receptor (TNF-R) superfamily. We observed that overexpression of OX40 activated NF-κB, which was inhibited by dominant negative forms of TRAF2, NF-κB-inducing kinase (NIK), and IkappaB kinase (IKK) α. This indicates that OX40 signaling leads to NF-κB activation through the same cascade as TNF-R2. We then investigated the negative regulatory function of TRAF3 on OX40-induced NF-κB activation. TRAF3 blocked OX40-, TRAF2-induced NF-κB activation, but not NIK- and IKKα-induced NF-κB activation, indicating that TRAF3 blocks the pathway between TRAF2 and NIK. C-terminal deletion mutants as well as the N-terminal deletion mutant of TRAF3 inhibited NF-κB activation induced by OX40 or TRAF2. Since TRAF3 bound to OX40 through the C-terminal TRAF domain, the C-terminal domain is likely to work as a dominant negative mutant to compete the recruitment of TRAF2 to the receptor, which transmits the signal from OX40 to the downstream, NIK kinase. On the other hand, the N-terminal domain of TRAF3 seems to affect the downstream of TRAF2 binding. Thus, it is suggested that TRAF3 actively inhibits NF-κB activation induced by OX40. (C) 2000 Academic Press.
AB - OX40 is a member of the tumor necrosis factor receptor (TNF-R) superfamily. We observed that overexpression of OX40 activated NF-κB, which was inhibited by dominant negative forms of TRAF2, NF-κB-inducing kinase (NIK), and IkappaB kinase (IKK) α. This indicates that OX40 signaling leads to NF-κB activation through the same cascade as TNF-R2. We then investigated the negative regulatory function of TRAF3 on OX40-induced NF-κB activation. TRAF3 blocked OX40-, TRAF2-induced NF-κB activation, but not NIK- and IKKα-induced NF-κB activation, indicating that TRAF3 blocks the pathway between TRAF2 and NIK. C-terminal deletion mutants as well as the N-terminal deletion mutant of TRAF3 inhibited NF-κB activation induced by OX40 or TRAF2. Since TRAF3 bound to OX40 through the C-terminal TRAF domain, the C-terminal domain is likely to work as a dominant negative mutant to compete the recruitment of TRAF2 to the receptor, which transmits the signal from OX40 to the downstream, NIK kinase. On the other hand, the N-terminal domain of TRAF3 seems to affect the downstream of TRAF2 binding. Thus, it is suggested that TRAF3 actively inhibits NF-κB activation induced by OX40. (C) 2000 Academic Press.
KW - IKKα
KW - NF-κB
KW - NIK
KW - OX40
KW - TRAF2
KW - TRAF3
UR - http://www.scopus.com/inward/record.url?scp=0034674314&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034674314&partnerID=8YFLogxK
U2 - 10.1006/bbrc.2000.2860
DO - 10.1006/bbrc.2000.2860
M3 - Article
C2 - 10860842
AN - SCOPUS:0034674314
SN - 0006-291X
VL - 272
SP - 856
EP - 863
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 3
ER -